Objective: To compare efficacy and safety of intravenous continuous infusion of oxycodone with morphine in patients with cancer pain.
Methods: A 5-day, randomized, open-label, exploratory study at 6 sites in the Republic of Korea. Sixty-six adults aged ≥19 years with moderate-to-severe cancer pain (Numeric Rating Scale [NRS] ≥ 4) were enrolled.